Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers.

被引：0
|
作者：
DeMatteo, Raymond
Goldman, Debra A.
Lin, Sabrina T.
Buonocore, Darren J.
Gao, JianJiong
Chang, Jason C.
Rekhtman, Natasha
Offin, Michael
Yu, Helena Alexandra
Isbell, James M.
Jones, David Randolph
Rudin, Charles M.
Travis, William D.
Kris, Mark G.
Drilon, Alexander E.
Arcila, Maria E.
Ginsberg, Michelle S.
Iasonos, Alexia
Liu, Dazhi
Li, Bob T.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21098
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [2] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [3] Outcomes of immune checkpoint inhibitors for postoperative recurrence of non-small cell lung cancer
    Itsuki Yuasa
    Masatsugu Hamaji
    Hiroaki Ozasa
    Yuichi Sakamori
    Hironori Yoshida
    Yojiro Yutaka
    Toshi Menju
    Toyohiro Hirai
    Hiroshi Date
    General Thoracic and Cardiovascular Surgery, 2023, 71 : 534 - 541
  • [4] Outcomes of immune checkpoint inhibitors for postoperative recurrence of non-small cell lung cancer
    Yuasa, Itsuki
    Hamaji, Masatsugu
    Ozasa, Hiroaki
    Sakamori, Yuichi
    Yoshida, Hironori
    Yutaka, Yojiro
    Menju, Toshi
    Hirai, Toyohiro
    Date, Hiroshi
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2023, 71 (09) : 534 - 541
  • [5] Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease
    Tasaka, Yuri
    Honda, Takayuki
    Nishiyama, Naoki
    Tsutsui, Toshiharu
    Saito, Hiroaki
    Watabe, Haruna
    Shimaya, Kazuhiro
    Mochizuki, Akifumi
    Tsuyuki, Shun
    Kawahara, Tatsuo
    Sakakibara, Rie
    Mitsumura, Takahiro
    Okamoto, Tsukasa
    Kobayashi, Masayoshi
    Chiaki, Tomoshige
    Yamashita, Takaaki
    Tsukada, Yoshikazu
    Taki, Reiko
    Jin, Yasuto
    Sakashita, Hiroyuki
    Natsume, Ichirou
    Saitou, Kazuhito
    Miyashita, Yoshihiro
    Miyazaki, Yasunari
    LUNG CANCER, 2021, 155 : 120 - 126
  • [6] Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Xue, Chongxiang
    Dong, Huijing
    Chen, Ying
    Lu, Xingyu
    Zheng, Shuyue
    Cui, Huijuan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 779 - 788
  • [7] Highlights on immune checkpoint inhibitors in non-small cell lung cancer
    Shen, Meng
    Ren, Xiubao
    TUMOR BIOLOGY, 2017, 39 (03)
  • [8] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [9] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    CANCER, 2018, 124 (02) : 248 - 261
  • [10] Clinical characteristic and outcomes of KRAS G13 mutant non-small cell lung cancers.
    Muthiah, Arun
    Chudasama, Rani
    Mingrino, Jennifer
    Olszewski, Adam J.
    Kurt, Habibe
    Garcia-Moliner, Maria
    Khan, Hina
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345